Publication | Closed Access

Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity

Maximal SensitivityTumoral PathologyMedicineEpithelioid MesotheliomaSurgical PathologyImmunologyHistopathologyPathologyThree-antibody Immunohistochemical PanelOncologyMalignant DiseaseTumor MicroenvironmentCancer Research